The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase

Experimental Parasitology

Volumn 130, Issue 3, 2012, Pages 183-188

  Da Silva, Edson Roberto ^a   Maquiaveli, Claudia do Carmo ^a   Magalhães, Prislaine Pupolin ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Arginase; Isoquercitrin; Leishmania; Polyamine; Quercetin; Quercitrin

Indexed keywords

ARGINASE; ARGININE; ASPARAGINE; CATECHOL DERIVATIVE; FLAVANOL DERIVATIVE; FLAVONE DERIVATIVE; ISOQUERCITRIN; MANGANESE; QUERCETIN; QUERCITRIN; RECOMBINANT ENZYME;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; IC 50; LEISHMANIA; MOLECULAR DOCKING; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ANTIPROTOZOAL AGENTS; ARGINASE; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; LEISHMANIA MEXICANA; MANGANESE; QUERCETIN;

LEISHMANIA AMAZONENSIS;

EID: 84857446373     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.01.015     Document Type: Article

References (39)

1. Aoki M.P., Guiñazú N.L., Pellegrini A.V., Gotoh T., Masih D.T., Gea S. Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes. Am. J. Physiol. Cell Physiol. 2004, 286:C206-212.
2. 50 to Ki values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Res. 2009, 37:W441-445.
3. Colotti G., Ilari A. Polyamine metabolism in Leishmania: from arginine to trypanothione. Amino Acids 2011, 40:269-285.
4. Cox J.D., Cama E., Colleluori D.M., Pethe S., Boucher J.L., Mansuy D., Ash D.E., Christianson D.W. Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase. Biochemistry 2001, 40:2689-2701.
5. Cuervo H., Pineda M.A., Aoki M.P., Gea S., Fresno M., Gironès N. Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J. Infect. Dis. 2008, 197:1772-1782.
6. da Silva E.R., Castilho T.M., Pioker F.C., de Paula Tomich, Silva C.H., Floeter-Winter L.M. Genomic organisation and transcription characterisation of the gene encoding Leishmania (Leishmania) amazonensis arginase and its protein structure prediction. Int. J. Parasitol. 2002, 32:727-737.
7. da Silva E.R., da Silva M.F., Fischer H., Mortara R.A., Mayer M.G., Framesqui K., Silber A.M., Floeter-Winter L.M. Biochemical and biophysical properties of a highly active recombinant arginase from Leishmania (Leishmania) amazonensis and subcellular localization of native enzyme. Mol. Biochem. Parasitol. 2008, 159:104-111.
8. Fawcett J.K., Scott J.E. A rapid and precise method for the determination of urea. J. Clin. Pathol. 1960, 13:156-159.
9. Frantz S. Drug discovery: playing dirty. Nature 2005, 437:942-943.
10. Gomes D.C., Muzitano M.F., Costa S.S., Rossi-Bergmann B. Effectiveness of the immunomodulatory extract of Kalanchoe pinnata against murine visceral leishmaniasis. Parasitology 2010, 137:613-618.
11. Hampton T. " Promiscuous" anticancer drugs that hit multiple targets may thwart resistance. JAMA 2004, 292:419-422.
12. Heby O., Persson L., Rentala M. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids 2007, 33:359-366.
13. Iniesta V., Gómez-Nieto L.C., Corraliza I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 2001, 193:777-784.
14. Iniesta V., Gómez-Nieto L.C., Molano I., Mohedano A., Carcelén J., Mirón C., Alonso C., Corraliza I. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 2002, 24:113-118.
15. Iniesta V., Carcelén J., Molano I., Peixoto P.M., Redondo E., Parra P., Mangas M., Monroy I., Campo M.L., Nieto C.G., Corraliza I. Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005, 73:6085-6090.
16. Jun T., Bochu W., Liancai Z. Hydrolytic cleavage of DNA by quercetin manganese(II) complexes. Colloids Surf. B Biointerfaces 2007, 55:149-152.
17. Kanyo Z.F., Scolnick L.R., Ash D.E., Christianson D.W. Structure of a unique binuclear manganese cluster in arginase. Nature 1996, 383:554-557.
18. Katalinić M., Rusak G., Domaćinović Barović J., Sinko G., Jelić D., Antolović R., Kovarik Z. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. Eur. J. Med. Chem. 2010, 45:186-192.
19. Kropf P., Fuentes J.M., Fähnrich E., Arpa L., Herath S., Weber V., Soler G., Celada A., Modolell M., Müller I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005, 19:1000-1002.
20. Kuntz I.D., Blaney J.M., Oatley S.J., Langridge R., Ferrin T.E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 1982, 161:269-288.
21. Leopoldini M., Russo N., Chiodo S., Toscano M. Iron chelation by the powerful antioxidant flavonoid quercetin. J. Agric. Food. Chem. 2006, 54:6343-6351.
22. Mittra B., Saha A., Chowdhury A.R., Pal C., Mandal S., Mukhopadhyay S., Bandyopadhyay S., Majumder H.K. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis. Mol. Med. 2000, 6:527-541.
23. Moustakas D.T., Lang P.T., Pegg S., Pettersen E., Kuntz I.D., Brooijmans N., Rizzo R.C. Development and validation of a modular, extensible docking program: DOCK 5. J. Comput. Aided Mol. Des. 2006, 20:601-619.
24. Muzitano M.F., Cruz E.A., de Almeida A.P., Da Silva S.A., Kaiser C.R., Guette C., Rossi-Bergmann B., Costa S.S. Quercitrin: an antileishmanial flavonoid glycoside from Kalanchoe pinnata. Planta Med. 2006, 72:81-83.
25. Muzitano M.F., Tinoco L.W., Guette C., Kaiser C.R., Rossi-Bergmann B., Costa S.S. The antileishmanial activity assessment of unusual flavonoids from Kalanchoe pinnata. Phytochemistry 2006, 67:2071-2077.
26. Muzitano M.F., Falcão C.A., Cruz E.A., Bergonzi M.C., Bilia A.R., Vincieri F.F., Rossi-Bergmann B., Costa S.S. Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis. Planta Med. 2009, 75:307-311.
27. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
28. Reguera R.M., Balaña-Fouce R., Showalter M., Hickerson S., Beverley S.M. Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol. Biochem. Parasitol. 2009, 165:48-56.
29. Richards F.M. Areas, volumes, packing and protein structure. Annu. Rev. Biophys. Bioeng. 1977, 6:151-176.
30. Riley E., Roberts S.C., Ullman B. Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I. Int. J. Parasitol. 2011, 41:545-552.
31. Roberts S.C., Tancer M.J., Polinsky M.R., Gibson K.M., Heby O., Ullman B. Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania. Characterization of gene deletion mutants. J. Biol. Chem. 2004, 279:23668-23678.
32. Sen G., Mukhopadhyay S., Ray M., Biswas T. Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J. Antimicrob. Chemother. 2008, 61:1066-1075.
33. Shin H., Cama E., Christianson D.W. Design of amino acid aldehydes as transition-state analogue inhibitors of arginase. J. Am. Chem. Soc. 2004, 126:10278-10284.
34. 2+ resin. Exp. Parasitol. 2010, 125:152-155.
35. Tasdemir D., Kaiser M., Brun R., Yardley V., Schmidt T.J., Tosun F., Rüedi P. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob. Agents Chemother. 2006, 50:1352-1364.
36. Taylor-Robinson A. Th1/Th2-regulated arginase availability modulates Leishmania infection. Trends Parasitol. 2001, 17:262.
37. Vannier-Santos M.A., Menezes D., Oliveira M.F., de Mello F.G. The putrescine analogue 1,4-diamino-2-butanone affects polyamine synthesis, transport, ultrastructure and intracellular survival in Leishmania amazonensis. Microbiology 2008, 154:3104-3111.
38. Wanderley J.L., Barcinski M.A. Apoptosis and apoptotic mimicry: the Leishmania connection. Cell. Mol. Life Sci. 2010, 67:1653-1659.
39. Wong I.L., Chan K.F., Burkett B.A., Zhao Y., Chai Y., Sun H., Chan T.H., Chow L.M. Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in leishmania. Antimicrob. Agents Chemother. 2007, 51:930-940.